SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venmax Drugs and Pharmaceuticals inform about compliances-certificate

14 Apr 2026 Evaluate
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, Venmax Drugs and Pharmaceuticals has enclosed certificate issued by CIL Securities, Registrar and Share Transfer Agent (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended March 31, 2026.

The above information is a part of company’s filings submitted to BSE.  

Venmax Drugs&Pharma Share Price

26.00 2.41 (10.22%)
16-Apr-2026 13:32 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.35
Dr. Reddys Lab 1222.90
Cipla 1231.40
Zydus Lifesciences 936.80
Lupin 2309.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×